CC
OPTN

Centiva Capital’s OptiNose OPTN Stock Holding History

Centiva Capital’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,747
Closed -$136K – 2476
2024
Q2 		$136K Buy
+8,747
New +$147K ﹤0.01% 1792

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Centiva Capital's OPTN Position: Q3 2024 in Review

Centiva Capital sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 8,747 shares — an estimated $136K sold.

Centiva Capital first reported a position in OPTN in Q2 2024 and held it in 1 quarter. The position peaked at $136K in Q2 2024. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Centiva Capital reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 8,747 OptiNose shares in Q3 2024, an estimated $136K.
  • Centiva Capital first reported a position in OptiNose in Q2 2024 and held it in 1 quarter.
  • Centiva Capital's OptiNose position peaked at $136K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.